INIS
glioblastomas
100%
kynurenine
100%
aryl hydrocarbons
71%
receptors
71%
patients
66%
tumors
30%
correlations
27%
computer codes
12%
tissues
12%
inflammation
11%
stratification
7%
hazards
7%
survival time
7%
tryptophan
7%
levels
7%
multivariate analysis
7%
tools
7%
blood
5%
failures
5%
tumor cells
5%
data
5%
density
5%
immunosuppression
5%
Keyphrases
Glioblastoma
50%
High-level Expression
50%
Prognostic Relevance
50%
Pathway Marker
50%
Kynurenine Pathway
50%
Tryptophan 2,3-dioxygenase (TDO2)
25%
Aryl Hydrocarbon Receptor
25%
Indoleamine 2,3-dioxygenase 1 (IDO1)
25%
Tumor Immunosuppressive Microenvironment
8%
Survival Rate
8%
Immunomodulating
8%
Poor Prognosis
8%
QuPath
8%
Marker Expression
8%
IDO2
8%
Immunohistochemistry
8%
Prognostic Factors
8%
Expression Level
8%
Tumor Core
8%
Kaplan-Meier Survival Analysis
8%
Patient Survival
8%
Multivariate Cox Regression
8%
Individualized Treatment
8%
Patient Stratification
8%
Survival Time
8%
Tissue Sampling
8%
Newly Diagnosed Glioblastoma
8%
Hazard Ratio
8%
Effector Target
6%
Pharmacology, Toxicology and Pharmaceutical Science
Kynurenine
100%
Glioblastoma
100%
Aromatic Hydrocarbon Receptor
75%
Neoplasm
33%
Immunosuppressive Agent
13%
Indoleamine 2,3 Dioxygenase
8%
Survival Rate
8%
Tryptophan 2,3 Dioxygenase
8%
Survival Time
8%
Tumor Microenvironment
5%
